HOME >> BIOLOGY >> NEWS
New report explores nanotechnology's future

ily merges and converges with other technologies and could change how we do just about everything." The report singles out advances in three underpinning technical areasresearch tools, information management, and assembly and manufacturingas fundamental to progress across the entire spectrum of nanotechnology research and development needs.

"Nanotechnology is in an early phase of development and, as of now, only relatively rudimentary nanostructures are being used to make improvements in existing materials and systems," noted Mihail Roco, NSF senior advisor for nanotechnology. "We are aiming at the systematic control of matter at the nanoscale to create revolutionary new generations of products and nanosystems as the primary foundation for converging and emerging technologies. For this reason, we need a transformative, responsible and anticipatory global governance approach for nanotechnology that involves both researchers and the public across many countries, scientific and engineering domains."

In the area of tools, workshop participants called for better devices for imaging, measuring, manipulating, and modeling at the nanoscale, or between 1 nanometer and 100 nanometers. As impressive as microscopes that "see" single atoms and as the other tools in the current generation of research instruments may seem, "these kinds of innovative nanotools are just the beginning," the report says. "The Nano Toolshed is still relatively empty." Filling it with more powerful instruments would translate into gains in scientifically useful knowledge, the starting point for next-generation nanotechnologies.

Researchers also expressed a need for integrated sets of probes and other tools capable of yielding the combined data necessary to gain a "fuller picture of the nanoworld in 3-D and in real time." However, gathering enormous volumes of information also presents practical challenges. Participants advised that scientists and policy planners should foc
'"/>

Contact: Sharon McCarter
sharon.mccarter@wilsoncenter.org
202-691-4016
Project on Emerging Nanotechnologies
23-Apr-2007


Page: 1 2 3 4

Related biology news :

1. Beyond Mesopotamia: A radical new view of human civilization reported in Science
2. A new report, Where Does the Nano Go? End-of-Life Regulation of Nanotechnologies
3. U-M, Israeli scientists report major advance in search for genes associated with colon cancer
4. Investigating Life in Extreme Environments report gives hints on facts of life
5. Wolves of Alaska became extinct 12,000 years ago, scientists report
6. Penn researchers report that gene therapy awakens the brain despite blindness from birth
7. Breakthrough developments in rheumatoid arthritis reported
8. Origins of nervous system found in genes of sea sponge, report scientists at UC Santa Barbara
9. ChemGenex reports successful personalized dosing of Quinamed at ASCO
10. DNA analysis suggests under-reported kills of threatened whales
11. 1 month post launch, Interactive Autism Network reports 13,000 participants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New report explores nanotechnology future

(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: